메뉴 건너뛰기
The Lancet
Volumn 372, Issue 9648, 2008, Pages 1460-1461
A vaccine for renal cancer
Author keywords

[No Author keywords available]
Indexed keywords

CANCER VACCINE; UNCLASSIFIED DRUG; VITESPEN;
EID: 54149097564     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61615-3     Document Type: Letter
Times cited : (5)
References (5)
  • 1
    • 46749131796 scopus 로고    scopus 로고
    • Vitespen: a vaccine for renal cancer?
    • Yang J.C. Vitespen: a vaccine for renal cancer?. Lancet 372 (2008) 92-93
    • (2008) Lancet , vol.372 , pp. 92-93
    • Yang, J.C.1
  • 2
    • 46749085802 scopus 로고    scopus 로고
    • An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
    • for the C-100-12 RCC Study Group
    • Wood C., Srivastava P., Bukowski R., et al., for the C-100-12 RCC Study Group. An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial. Lancet 372 (2008) 145-154
    • (2008) Lancet , vol.372 , pp. 145-154
    • Wood, C.1    Srivastava, P.2    Bukowski, R.3
  • 3
    • 39749132274 scopus 로고    scopus 로고
    • Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatments
    • Stebbing J., Wood C., Atkins M., et al. Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatments. Cancer 112 (2008) 955-961
    • (2008) Cancer , vol.112 , pp. 955-961
    • Stebbing, J.1    Wood, C.2    Atkins, M.3
  • 4
    • 0037108696 scopus 로고    scopus 로고
    • Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings
    • Belli F., Testori A., Rivoltini L., et al. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J Clin Oncol 20 (2002) 4169-4180
    • (2002) J Clin Oncol , vol.20 , pp. 4169-4180
    • Belli, F.1    Testori, A.2    Rivoltini, L.3
  • 5
    • 10744233222 scopus 로고    scopus 로고
    • Vaccination with autologous tumor-derived heatshock protein gp96 after liver resection for metastatic colorectal cancer
    • Mazzaferro V., Coppa J., Carrabba M.G., et al. Vaccination with autologous tumor-derived heatshock protein gp96 after liver resection for metastatic colorectal cancer. Clin Cancer Res 9 (2003) 3235-3245
    • (2003) Clin Cancer Res , vol.9 , pp. 3235-3245
    • Mazzaferro, V.1    Coppa, J.2    Carrabba, M.G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.